Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute
Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with th...
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
L1 Capital, an investment management firm, released its "L1 Capital International Fund" (unhedged) fourth-quarter 2025 investor letter. A copy of the lette...
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse ArticlesHims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with th...
The findings have been tested in the real world.
The wellness platform's results arrived amid heightened legal and regulatory scrutiny over its weight-loss-drug business.
Stock Market Today: The Dow Jones index dropped Monday on higher Trump tariffs. Novo stock plunged on weight-loss drug trial results.
Novo Nordisk shares were under pressure on Monday as the struggling Danish pharmaceutical said a head-to-head study found a drug in development didn't cut...
"My son is smart - he really is - but he was in love."
The pharmaceutical giant announced profit in line with expectations and revenue that slightly beat forecasts on Tuesday.
Hims & Hers stock tumbled in early action on Monday after the U.S. company quickly reversed plans to introduce its own version of Novo Nordisk's Wegovy ora...
Weight-loss drugs to compete on biggest stage with Super Bowl ads
STORY: From a massive tech stock sell off to a SpaceX mega deal...This is the Week in Numbers.:: The Week in Numbers:: 11%11% was the share plunge for Amaz...
Novo's Wegovy pill makes 'encouraging' start in weight-loss race vs Lilly
Eli Lilly shares dip as FDA delays decision on weight-loss pill